US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 41.140
  • -1.980-4.59%
Close Jun 14 16:00 ET
  • 41.140
  • 0.0000.00%
Post 16:05 ET
2.40BMarket Cap-22395P/E (TTM)

About Apogee Therapeutics Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Company Profile

SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Websitehttp://www.apogeetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Henderson, M.D.
  • Chief Executive Officer and Director
  • 1.17M
  • Jane Pritchett Henderson
  • Chief Financial Officer and Chief Accounting Officer
  • 1.72M
  • Dr. Carl Dambkowski, M.D.
  • Chief Medical Officer
  • 870.83K
  • Mark C. McKenna
  • Chairman of the Board
  • 972.87K
  • Dr. Lisa L. Bollinger, M.D.
  • Director
  • --
  • Jennifer A. Fox
  • Independent Director
  • 414.57K
  • William B.J. Jones, Jr
  • Independent Director
  • 411.66K
  • Peter Harwin
  • Independent Director
  • 668.57K
  • Dr. Andrew Gottesdiener, M.D.
  • Independent Director
  • 666.57K
  • Tomas Kiselak
  • Independent Director
  • 662.82K
  • Nimish Shah
  • Independent Director
  • 664.82K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg